Cite
HARVARD Citation
Diaz-Manera, J. et al. (2021). Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. Lancet neurology. 20 (12), pp. 1012-1026. [Online].